(Q84960392)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797564%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

title

Metabolic syndrome and chronic kidney disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797564%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Metabolic Syndrome and Chronic Kidney Disease (English)

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

2 July 2024

1 reference

chronic renal insufficiency

1 reference

Gianfranco Guarnieri

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797564%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Michela Zanetti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797564%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Pierandrea Vinci

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797564%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Maria Rosa Cattin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797564%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Alesia Pirulli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797564%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

Rocco Barazzoni

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797564%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20797564

2 July 2024

publication date

1 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797564%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

12 February 2020

https://api.elsevier.com/content/article/PII:S1051227610001172?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

https://api.elsevier.com/content/article/PII:S1051227610001172?httpAccept=text/plain

2 July 2024

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Journal of Renal Nutrition

2 July 2024

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797564%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797564%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

issue

5 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797564%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

page(s)

S19-23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797564%20AND%20SRC:MED&resulttype=core&format=json

Prevalence of overweight and obesity in the United States, 1999-2004

12 February 2020

cites work

1

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Obesity epidemic migrates east

2 July 2024

2

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds

2 July 2024

4

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome

2 July 2024

5

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Obesity and Risk for Chronic Renal Failure

2 July 2024

6

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

The metabolic syndrome and chronic kidney disease in U.S. adults

2 July 2024

7

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults

2 July 2024

8

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease

2 July 2024

9

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy

2 July 2024

10

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Oxidative stress as a major culprit in kidney disease in diabetes

2 July 2024

11

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Contributions of angiotensin II and tumor necrosis factor-alpha to the development of renal fibrosis

2 July 2024

12

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Progression of chronic renal disease

2 July 2024

13

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling.

2 July 2024

14

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: potential role in diabetic nephropathy

2 July 2024

15

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy

2 July 2024

17

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

A severe diabetic nephropathy model with early development of nodule-like lesions induced by megsin overexpression in RAGE/iNOS transgenic mice

2 July 2024

18

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation.

2 July 2024

19

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome

2 July 2024

20

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Role of fat mass and adipokines in chronic kidney disease

2 July 2024

21

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Increased oxidative stress in obesity and its impact on metabolic syndrome

2 July 2024

22

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Low fat adiponectin expression is associated with oxidative stress in nondiabetic humans with chronic kidney disease--impact on plasma adiponectin concentration

2 July 2024

23

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Insulin resistance and risk of chronic kidney disease in nondiabetic US adults

2 July 2024

24

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Obesity, Inflammation, and Insulin Resistance

2 July 2024

25

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion

2 July 2024

26

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [seecomments]

2 July 2024

28

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Circulating ghrelin levels are decreased in human obesity.

2 July 2024

29

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Hyperleptinemia prevents increased plasma ghrelin concentration during short-term moderate caloric restriction in rats.

2 July 2024

30

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Relationships between desacylated and acylated ghrelin and insulin sensitivity in the metabolic syndrome

2 July 2024

31

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Low Plasma Ghrelin Is Associated With Insulin Resistance, Hypertension, and the Prevalence of Type 2 Diabetes

2 July 2024

32

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Ghrelin enhances in vivo skeletal muscle but not liver AKT signaling in rats

2 July 2024

33

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle

2 July 2024

34

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Higher total ghrelin levels are associated with higher insulin-mediated glucose disposal in non-diabetic maintenance hemodialysis patients

2 July 2024

35

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Ghrelin treatment of chronic kidney disease: improvements in lean body mass and cytokine profile

2 July 2024

36

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Combined effects of ghrelin and higher food intake enhance skeletal muscle mitochondrial oxidative capacity and AKT phosphorylation in rats with chronic kidney disease.

2 July 2024

37

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis

2 July 2024

38

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients

2 July 2024

39

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Inflammation in end-stage renal failure: could it be treated?

2 July 2024

40

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Skeletal muscle, cytokines, and oxidative stress in end-stage renal disease

2 July 2024

41

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Insulin resistance in uremia

2 July 2024

42

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease

2 July 2024

43

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Insulin resistance is associated with skeletal muscle protein breakdown in non-diabetic chronic hemodialysis patients.

2 July 2024

44

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy

2 July 2024

45

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling

2 July 2024

46

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Development of a diagnostic method for detecting increased muscle protein degradation in patients with catabolic conditions

2 July 2024

47

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Metabolic syndrome after kidney transplantation

2 July 2024

51

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

Metabolic syndrome after kidney transplantation

2 July 2024

52

1 reference

https://api.crossref.org/works/10.1053/J.JRN.2010.05.006

2 July 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20797564%20AND%20SRC:MED&resulttype=core&format=json

12 February 2020

1 reference